Claudia Gotz
Homburg, SL 66421, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Discovery and characterization of a novel class of cyclic peptidic compounds inhibiting the subunit interaction of the protein kinase CK2α2β2 holoenzyme.
Journal: RSC chemical biology
Published: March 12, 2026
Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines.
Journal: Molecules (Basel, Switzerland)
Published: November 26, 2025
Gene expression changes in pancreatic α-cell lines following knock-out Of either CK2α or CK2α'.
Journal: Biological research
Published: August 18, 2025
CK2 regulates somatostatin expression in pancreatic delta cells.
Journal: Islets
Published: June 06, 2025
70 years of CK2: still exciting, essential - and enigmatic!
Journal: Biological chemistry
Published: June 03, 2025
Protein kinase CK2 contributes to glucose homeostasis.
Journal: Biological chemistry
Published: December 13, 2024
Discovery of 7,9-Dibromo-dihydrodibenzofuran as a Potent Casein Kinase 2 (CK2) Inhibitor: Synthesis, Biological Evaluation, and Structural Studies on E-/Z-Isomers.
Journal: ACS pharmacology & translational science
Published: July 18, 2024
1,2,3-Triazole-totarol conjugates as potent PIP5K1α lipid kinase inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: December 18, 2023
CK2 activity is crucial for proper glucagon expression.
Journal: Diabetologia
Published: August 03, 2023
C-Myc/H19/miR-29b axis downregulates nerve/glial (NG)2 expression in glioblastoma multiforme.
Journal: Molecular therapy. Nucleic acids
Published: June 01, 2023
Last Updated: 09/26/2026